DGX Insider Trading

Insider Ownership Percentage: 0.79%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,202,976.78

Quest Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40M-$20M$0$20M$40MTotal Insider BuyingTotal Insider Selling

Quest Diagnostics Share Price & Price History

Current Price: $167.92
Price Change: Price Decrease of -1.36 (-0.80%)
As of 04/2/2025 04:58 PM ET

This chart shows the closing price history over time for DGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$167.92Closing price on 04/02/25:

SEC Filings (Institutional Ownership Changes) for Quest Diagnostics (NYSE:DGX)

88.06% of Quest Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$715ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1B$0$1BTotal InflowsTotal Outflows
Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More on Quest Diagnostics

Today's Range

Now: $167.92
Low: $167.26
High: $170.41

50 Day Range

MA: $167.34
Low: $151.43
High: $176.81

52 Week Range

Now: $167.92
Low: $125.42
High: $178.87

Volume

940,539 shs

Average Volume

913,704 shs

Market Capitalization

$18.64 billion

P/E Ratio

21.84

Dividend Yield

1.81%

Beta

0.92

Who are the company insiders with the largest holdings of Quest Diagnostics?

Quest Diagnostics' top insider shareholders include:
  1. Catherine T Doherty (EVP)
  2. Michael E Prevoznik (SVP)
  3. Michael J Deppe (CAO)
  4. Vicky B Gregg (Director)
  5. Karthik Kuppusamy (SVP)
  6. Mark E Delaney (SVP)
Learn More about top insider investors at Quest Diagnostics.

Who are the major institutional investors of Quest Diagnostics?

Quest Diagnostics' top institutional shareholders include:
  1. MassMutual Private Wealth & Trust FSB — 0.02%
  2. First Financial Bank Trust Division — 0.00%
Learn More about top institutional investors of Quest Diagnostics stock.

Which institutional investors are selling Quest Diagnostics stock?

In the last quarter, DGX stock was sold by these institutional investors:
  1. First Financial Bank Trust Division
  2. MassMutual Private Wealth & Trust FSB
In the previous year, company insiders that have sold Quest Diagnostics company stock include:
  1. Catherine T Doherty (EVP)
  2. Michael E Prevoznik (SVP)
  3. Michael J Deppe (CAO)
  4. Vicky B Gregg (Director)
  5. Karthik Kuppusamy (SVP)
  6. Mark E Delaney (SVP)
Learn More investors selling Quest Diagnostics stock.